Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Once Weekly Semaglutide in Adults With Obesity and Inadequately Controlled Type 1 Diabetes Using Hybrid Closed-Loop System.

NCT05537233 is registered in ClinicalTrials.gov with Viral N. Shah as lead sponsor.

NCT NCT05537233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05537233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Once Weekly Semaglutide in Adults With Obesity and Inadequately Controlled Type 1 Diabetes Using Hybrid Closed-Loop System.
Lead sponsor
Viral N. Shah
Phase
Phase 2
Overall status
Completed
Start date
April 11, 2023
Completion date
August 6, 2024
Enrollment
115 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, type 1 diabetes